John Chiminski

Insider profile

Currently holds positions in Catalent Inc and Juniper Pharmaceuticals Inc

Performance

Overall performance
3.9

Performance over holding periods
3.9
30 days 90 days 120 days
Average return 22% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Catalent Inc Feb. 13, 2019 -
President, Chief Executive Officer Juniper Pharmaceuticals Inc Aug. 13, 2018 -
Independent Director Biogen Inc June 19, 2019 - Dec. 1, 2019
Chairman of the Board, President, Chief Executive Officer Catalent Inc Oct. 25, 2016 - Feb. 13, 2019
President, Chief Executive Officer, Director Catalent Inc March 1, 2009 - Oct. 25, 2016

John Chiminski's trades of Catalent Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
116.13
Quantity 61,408
Value US$1,927,170
Transaction date
Sale
Price
479.33
Quantity 28,971 -24.7%
Value US$1,608,886
Transaction date
Sale
Price
27.52
Quantity 72,471 +15.4%
Value US$3,585,522
Transaction date
Purchase
Price
5.18
Quantity 18,000 +367.3%
Value US$93,272
Transaction date
Planned sale
Price
132.86
Quantity 4,888 -3.3%
Value US$649,420
Transaction date
Planned sale
Price
132.18
Quantity 64,031 -30.3%
Value US$8,463,618
Transaction date
Planned sale
Price
131.21
Quantity 26,662 -11.2%
Value US$3,498,321
Transaction date
Planned sale
Price
130.39
Quantity 21,245 -8.2%
Value US$2,770,136
Transaction date
Planned sale
Price
129.22
Quantity 12,700 -4.7%
Value US$1,641,094
Transaction date
Planned sale
Price
128.10
Quantity 18,510 -6.4%
Value US$2,371,131
Transaction date
Planned sale
Price
127.34
Quantity 4,601 -1.6%
Value US$585,891
Transaction date
Planned sale
Price
107.07
Quantity 800 -0.5%
Value US$85,656
Transaction date
Planned sale
Price
106.24
Quantity 111,641 -40.4%
Value US$11,860,740
Transaction date
Planned sale
Price
105.64
Quantity 70,583 -20.4%
Value US$7,456,388
Transaction date
Planned sale
Price
105.16
Quantity 42,220 -20.5%
Value US$4,439,855
Transaction date
Planned sale
Price
86.05
Quantity 173,040 -49.9%
Value US$14,890,092
Transaction date
Planned sale
Price
85.27
Quantity 9,191 -2.6%
Value US$783,717
Transaction date
Planned sale
Price
48.84
Quantity 97,043 -30.2%
Value US$4,739,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-01 2023-08-01 PrS Proposed sale
61,408
116.13
US$1,927,170
61,408 116.13 US$1,927,170
2022-08-26 2022-08-25 S Sale
28,971 -24.7%
479.33
US$1,608,886
28,971 -24.7% 479.33 US$1,608,886
2022-07-28 2022-07-26 S Sale
72,471 +15.4%
27.52
US$3,585,522
72,471 +15.4% 27.52 US$3,585,522
2022-03-15 2022-03-11 B Purchase
18,000 +367.3%
5.18
US$93,272
18,000 +367.3% 5.18 US$93,272
2021-10-05 2021-10-01 PlS Planned sale
4,888 -3.3%
132.86
US$649,420
4,888 -3.3% 132.86 US$649,420
2021-10-05 2021-10-01 PlS Planned sale
64,031 -30.3%
132.18
US$8,463,618
64,031 -30.3% 132.18 US$8,463,618
2021-10-05 2021-10-01 PlS Planned sale
26,662 -11.2%
131.21
US$3,498,321
26,662 -11.2% 131.21 US$3,498,321
2021-10-05 2021-10-01 PlS Planned sale
21,245 -8.2%
130.39
US$2,770,136
21,245 -8.2% 130.39 US$2,770,136
2021-10-05 2021-10-01 PlS Planned sale
12,700 -4.7%
129.22
US$1,641,094
12,700 -4.7% 129.22 US$1,641,094
2021-10-05 2021-10-01 PlS Planned sale
18,510 -6.4%
128.10
US$2,371,131
18,510 -6.4% 128.10 US$2,371,131
2021-10-05 2021-10-01 PlS Planned sale
4,601 -1.6%
127.34
US$585,891
4,601 -1.6% 127.34 US$585,891
2021-03-22 2021-03-19 PlS Planned sale
800 -0.5%
107.07
US$85,656
800 -0.5% 107.07 US$85,656
2021-03-22 2021-03-19 PlS Planned sale
111,641 -40.4%
106.24
US$11,860,740
111,641 -40.4% 106.24 US$11,860,740
2021-03-22 2021-03-19 PlS Planned sale
70,583 -20.4%
105.64
US$7,456,388
70,583 -20.4% 105.64 US$7,456,388
2021-03-22 2021-03-18 PlS Planned sale
42,220 -20.5%
105.16
US$4,439,855
42,220 -20.5% 105.16 US$4,439,855
2020-10-05 2020-10-02 PlS Planned sale
173,040 -49.9%
86.05
US$14,890,092
173,040 -49.9% 86.05 US$14,890,092
2020-10-05 2020-10-02 PlS Planned sale
9,191 -2.6%
85.27
US$783,717
9,191 -2.6% 85.27 US$783,717
2019-10-09 2019-10-07 PlS Planned sale
97,043 -30.2%
48.84
US$4,739,580
97,043 -30.2% 48.84 US$4,739,580